Meeting of the National Vaccine Advisory Committee, 28826-28827 [E8-11065]

Download as PDF 28826 Federal Register / Vol. 73, No. 97 / Monday, May 19, 2008 / Notices FEDERAL RESERVE SYSTEM DEPARTMENT OF HEALTH AND HUMAN SERVICES National Committee on Vital and Health Statistics: Meeting Formations of, Acquisitions by, and Mergers of Bank Holding Companies pwalker on PROD1PC71 with NOTICES The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than June 13, 2008. A. Federal Reserve Bank of Atlanta (Steve Foley, Vice President) 1000 Peachtree Street, N.E., Atlanta, Georgia 30309: 1. High Trust Bancorp, Inc., to become a bank holding company by acquiring 100 percent of the voting shares of High Trust Bank, both of Stockbridge, Georgia. Board of Governors of the Federal Reserve System, May 14, 2008. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E8–11135 Filed 5–16–08; 8:45 am] BILLING CODE 6210–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee Pursuant to the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) announces the following advisory committee meeting. AGENCY: Name: National Committee on Vital and Health Statistics (NCVHS). Time and Date: May 21, 2008—9 a.m.–3 p.m., May 22, 2008—10 a.m.–2 p.m. Place: Renaissance Washington DC Hotel, 999 9th Street, NW., Washington, DC 20001, Tel: (202) 898–9000. Status: Open. Purpose: At this meeting the Committee will hear presentations and hold discussions on several health data policy topics. On the first day the Committee will hear updates from the Department by the Data Council and the HHS Office of the National Coordinator (ONC). They will also discuss letters to the HHS Secretary on hospital surge capacity and e-prescribing standards and long term care. Later in the afternoon there will be an update on classification issues in healthcare terminology. On the morning of the second day the Committee will continue the discussions on the letters on surge capacity and e-prescribing standards. The remainder of the time will be spent discussing future agenda items and Committee administrative operations. The times shown above are for the full Committee meeting. Subcommittee breakout sessions can be scheduled for late in the afternoon of the first day and in the morning prior to the full Committee meeting on the second day. Agendas for these breakout sessions will be posted on the NCVHS Web site (URL below) when available. Contact Person for More Information: Substantive program information as well as summaries of meetings and a roster of committee members may be obtained from Marjorie S. Greenberg, Executive Secretary, NCVHS, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Room 2402, Hyattsville, Maryland 20782, telephone (301) 458–4245. Information also is available on the NCVHS home page of the HHS Web site: https:// www.ncvhs.hhs.gov/, where further information including an agenda will be posted when available. Should you require reasonable accommodation, please contact the CDC Office of Equal Employment Opportunity on (301) 458–4EEO (4336) as soon as possible. Dated: May 13, 2008. James Scanlon, Deputy Assistant Secretary for Planning and Evaluation (SDP), Office of the Assistant Secretary for Planning and Evaluation. [FR Doc. E8–11070 Filed 5–16–08; 8:45 am] BILLING CODE 4151–05–P VerDate Aug<31>2005 17:18 May 16, 2008 Jkt 214001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice. SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting. The meeting is open to the public. DATES: The meeting will be held on June 3, 2008, from 9 a.m. to 5 p.m., and on June 4, 2008, from 9 a.m. to 4 p.m. ADDRESSES: Residence Inn Capitol Hotel, 333 E Street, SW., Washington, DC 20024. FOR FURTHER INFORMATION CONTACT: Ms. Julie Moreno, National Vaccine Program Office, Department of Health and Human Services, Room 443–H Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201; (202) 690–5566, nvpo@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The National Vaccine Advisory Committee was established to provide advice and make recommendations to the Director of the National Vaccine Program, on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. Topics to be discussed at the meeting include Departmental vaccine priorities, vaccine safety, vaccine financing issues, and adolescent and adult immunization. A tentative agenda is currently available on the NVAC Web site: https:// www.hhs.gov/nvpo/nvac. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to five minutes per speaker. Any members of E:\FR\FM\19MYN1.SGM 19MYN1 Federal Register / Vol. 73, No. 97 / Monday, May 19, 2008 / Notices the public who wish to have printed material distributed to NVAC members should submit materials to the Executive Secretary, NVAC, through the contact person listed above prior to close of business May 30, 2008. Preregistration is required for both public attendance and comment. Any individual who wishes to attend the meeting and/or participate in the public comment session should e-mail nvpo@hhs.gov or call 202–690–5566. Dated: May 12, 2008. Bruce Gellin, Director, National Vaccine Program Office. [FR Doc. E8–11065 Filed 5–16–08; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Announcement of Third Meeting of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020 Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science, Office of Disease Prevention and Health Promotion. ACTION: Notice of meeting. AGENCY: pwalker on PROD1PC71 with NOTICES Authority: 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended. The Committee is governed by the provision of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. SUMMARY: The U.S. Department of Health and Human Services (HHS) announces the third meeting of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020. All Committee meetings are open to the public. The Committee will review the nation’s health promotion and disease prevention objectives and efforts to develop goals and objectives to improve the health status and reduce health risks for Americans by the year 2020. The Committee will provide to the Secretary of Health and Human Services advice and consultation to facilitate the process for developing and implementing the next iteration of national health promotion and disease prevention goals and objectives and provide advice for initiatives to occur during the initial implementation phase of the goals and objectives. HHS will use the advice that is provided to develop recommendations to form the national health promotion and disease prevention objectives for 2020 and the process for implementing the objectives. VerDate Aug<31>2005 17:18 May 16, 2008 Jkt 214001 The intent is to develop and launch objectives designed to improve the health status and reduce health risks for Americans by the year 2020. DATES: The Committee will meet on Thursday, June 5, 2008 from 9 a.m. until 5:30 p.m., and Friday, June 6, 2008 from 9 a.m. until 4:30 p.m. ADDRESSES: The meeting will be held at the Hyatt Regency Crystal City at Reagan National Airport, located at 2799 Jefferson Davis Highway, Arlington, Virginia 22202. FOR FURTHER INFORMATION CONTACT: Carter Blakey, Designated Federal Officer, Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020, U.S. Department of Health and Human Services, Office of Public Health and Science, Office of Disease Prevention and Health Promotion, 1101 Wootton Parkway, Room LL–100, Rockville, MD 20852, (240) 453–8254 (telephone), (240) 453–8281 (fax). Additional information is available on the Internet at https://www.healthypeople.gov. Registration questions may be directed to Hilary Scherer at HP2020@norc.org (e-mail), (301) 634–9374 (phone), or (301) 634–9301 (fax). SUPPLEMENTARY INFORMATION: The names of the 13 members of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020 are available at https:// www.healthypeople.gov. Purpose of Meeting: The Committee will consider the work of its various subcommittees, hear presentations on select topics, and deliberate next steps. The Committee will also hear oral comments from the public to help inform them as they prepare their recommendations to the Secretary. Every 10 years, through the Healthy People initiative, HHS leverages scientific insights and lessons from the past decade, along with the new knowledge of current data, trends, and innovations to develop the next iteration of national health promotion and disease prevention objectives. Healthy People provides science-based, 10-year national objectives for promoting health and preventing disease. Healthy People 2020 will reflect assessments of major risks to health and wellness, changing public health priorities, and emerging technologies related to our nation’s health preparedness and prevention. Public Participation at Meeting: Members of the public are invited to observe the Committee meeting. A portion of the meeting agenda will be allocated for committee members to PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 28827 hear public comments. All individuals wishing to observe and/or make comments must pre-register at https:// www.healthypeople.gov. Due to time constraints, a limited number of scheduled time slots for public comments will be available on a firstcome-first-served basis through preregistration. Comments will also be limited to 1–2 minutes per individual. Attendees that do not pre-register to make comments cannot be guaranteed an opportunity to have his or her comments heard during the meeting. Individuals are encouraged to submit their comments in writing in advance of the meeting through the pre-registration process. Written comments are also welcome throughout the development process of the national health promotion and disease prevention objectives for 2020. They can be submitted through the Healthy People Web site at: https:// www.healthypeople.gov/hp2020/ comments/ or they can be e-mailed to HP2020@hhs.gov. Registrations must be completed by 5:30 p.m. EST on Monday, June 2, 2008. Space for the meeting is limited. Registrations will be accepted until maximum room capacity is reached. A waiting list will be maintained should registrations exceed room capacity. Individuals on the waiting list will be contacted as additional space for the meeting becomes available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. Dated: May 13, 2008. Penelope Slade Royall, RADM, USPHS, Deputy Assistant Secretary for Health (Disease Prevention and Health Promotion), Office of Disease Prevention and Health Promotion. [FR Doc. E8–11071 Filed 5–16–08; 8:45 am] BILLING CODE 4150–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Solicitation for Public Comments Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice. AGENCY: SUMMARY: The Department of Health and Human Services (DHHS) is hereby giving notice that the National Vaccine Program Office (NVPO) is seeking comments on a draft document that has been prepared for presentation to the National Vaccine Advisory Committee (NVAC). E:\FR\FM\19MYN1.SGM 19MYN1

Agencies

[Federal Register Volume 73, Number 97 (Monday, May 19, 2008)]
[Notices]
[Pages 28826-28827]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-11065]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of Public Health and Science.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (DHHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a 
meeting. The meeting is open to the public.

DATES: The meeting will be held on June 3, 2008, from 9 a.m. to 5 p.m., 
and on June 4, 2008, from 9 a.m. to 4 p.m.

ADDRESSES: Residence Inn Capitol Hotel, 333 E Street, SW., Washington, 
DC 20024.

FOR FURTHER INFORMATION CONTACT: Ms. Julie Moreno, National Vaccine 
Program Office, Department of Health and Human Services, Room 443-H 
Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, 
DC 20201; (202) 690-5566, nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The National Vaccine Advisory Committee was 
established to provide advice and make recommendations to the Director 
of the National Vaccine Program, on matters related to the Program's 
responsibilities. The Assistant Secretary for Health serves as Director 
of the National Vaccine Program.
    Topics to be discussed at the meeting include Departmental vaccine 
priorities, vaccine safety, vaccine financing issues, and adolescent 
and adult immunization. A tentative agenda is currently available on 
the NVAC Web site: https://www.hhs.gov/nvpo/nvac.
    Public attendance at the meeting is limited to space available. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the designated contact person. Members of the public will have 
the opportunity to provide comments at the meeting. Public comment will 
be limited to five minutes per speaker. Any members of

[[Page 28827]]

the public who wish to have printed material distributed to NVAC 
members should submit materials to the Executive Secretary, NVAC, 
through the contact person listed above prior to close of business May 
30, 2008. Pre-registration is required for both public attendance and 
comment. Any individual who wishes to attend the meeting and/or 
participate in the public comment session should e-mail nvpo@hhs.gov or 
call 202-690-5566.

    Dated: May 12, 2008.
Bruce Gellin,
Director, National Vaccine Program Office.
 [FR Doc. E8-11065 Filed 5-16-08; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.